Imunon, Inc. — Director's Dealing 2015

Jun 19, 2015

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Celsion CORP (CLSN)
CIK: 0000749647
Period of Report: 2015-06-19

Reporting Person: Tardugno Michael H (Director, CEO)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2015-06-19	Option to Purchase Celsion Corporation Common Stock	$2.39	A	65000	Acquired	2025-06-19	Celsion Corporation Common Stock (65000)	Direct

Footnotes

F1: Represents the closing price of Celsion Corporation Common Stock on the date of grant.

F2: The option vests in thirds on June 19, 2015, June 19, 2016 and June 19, 2017.